{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-015711","form_type":"8-K","ticker":null,"cik":"0001792581","company_name":"Kiromic Biopharma, Inc.","filed_at":"2023-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.266008+00:00","generated_at":"2026-06-10T19:16:00.207879+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Kiromic BioPharma receives Nasdaq delisting notice; stock moves to OTC Pink","bullets":["Received formal notice on Sept 12, 2023 for failure to comply with Nasdaq Listing Rule 5550(b)(1).","Trading on Nasdaq Capital Market suspended effective Sept 14, 2023.","Common stock will trade on OTC Pink Sheets under ticker KRBP starting Sept 14.","Company will pursue uplisting to OTCQB but no assurance of market development.","Delisting not expected to impact day-to-day operations, per company statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-015711","json":"https://secwatch.observer/filing/0001558370-23-015711.json","markdown":"https://secwatch.observer/filing/0001558370-23-015711.md","text":"https://secwatch.observer/filing/0001558370-23-015711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/0001558370-23-015711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/krbp-20230912x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T19:16:00.207879+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a9fb53fb95fd955b3ed343ddcb2ab9cf0ef7e57","claim":"Kiromic Biopharma, Inc. received a nasdaq delisting notice notice regarding other.","evidence_excerpt":"September 12, 2023, Kiromic Biopharma, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that it would delist the Company’s shares of common stock from the Nasdaq Capital Market upon the opening of trading on September 14, 2023. The Company’s common stock will be traded on the OTC Pink Sheets while it pursues an uplisting to the OTCQB exchange and seeks to establish relationships with market makers to provide additional trading opportunities in the Company’s stock. However, there can be no assurance that a market for the Company’s shares w","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1792581/000155837023015711/0001558370-23-015711-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}